ZHZhaokai He

Zhaokai He

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Zhaokai He has a total of 34 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    From Pharmacovigilance Signals to Multilevel Computational Evidence in Drug-Related Seizures: Retrospective Analysis of FDA Adverse Event Reporting System Data (Preprint)

    by Lei Wang, Yangfan Zou, Zhaokai He, Liang Xia, Songjie Zhang

    BACKGROUND Drug-related seizures require timely recognition in complex treatment settings, but spontaneous-report associations, whole-molecule features, and network-structural clues are rarely examined together. OBJECTIVE To characterize drug-related seizures by integrating pharmacovigilance, high-dimensional chemical space, machine-learning applicability, and independent network and structural analyses. METHODS We curated FAERS data from 2004Q1 through 2026Q1 and defined seizures using SEIZURE plus historical CONVULSION. After deduplication and ingredient mapping, ROR, PRR, BCPNN, and MGPS were evaluated across drug-role and indication-exclusion specifications. We analyzed ring topology, Morgan fingerprints, and USRCAT space, then audited a benchmark XGBoost model using an applicability domain and refits. Separately, 12 neuro-oncology drugs entered network analysis; FAERS-positive drugs related to at least 2 hubs underwent docking and one 100-ns molecular-dynamics trajectory per complex. RESULTS The cohort contained 167,223 unique seizure-related reports. Auditing retained 68 of 844 eligible ingredients across specifications. Morgan and USRCAT spaces showed same-label enrichment in all 8 tests (empirical P=1/10,001; all Benjamini-Hochberg significant). XGBoost held-out accuracy was 0.783 and Active recall was 0.364. Eleven of 12 primary drug structures were in-domain, although 7 had unseen Murcko scaffolds. The 486 drug-associated targets and 3951 epilepsy-associated genes shared 236 genes, yielding 15 exploratory hubs. Independently selected everolimus and vincristine were screened against human HSP90AA1 and the 5EWM cross-species interface comprising Xenopus laevis GRIN1 chain C and human GRIN2B chain D. Four trajectories showed differential behavior; vincristine-HSP90AA1 had the most consistently low RMSD profile. CONCLUSIONS Integrating reporting robustness, whole-molecule organization, model-scope auditing, and independent network-structural analysis produced a traceable strategy for prioritizing drug-context combinations and testable molecular hypotheses.

  • Open Access

    Influenza Vaccination Intention Among Caregivers in the Context of Highly Publicized Influenza Events: A Cross-Sectional Survey of Caregivers of Kindergarten and Primary School Children in Zhejiang, China

    by Zhaokai He, Minchao Li, Yun Zeng, Rui Zhang, Jing Tao, Yumeng Wu, Jianwu Li, Guiwei Zhu, Qianhui Zheng, Junqi Yang, et al.

    Objective: This study assessed the influence of a highly publicized influenza-related death event on caregivers’ influenza vaccination intention for kindergarten and primary school children in Zhejiang, China, and identified associated factors. Methods: A cross-sectional survey was conducted from March to April 2025 using a multi-stage, stratified cluster sampling method across 10 districts/counties. Caregivers completed electronic questionnaires covering sociodemographics, event awareness, vaccination history, hesitancy, and cognitive attitudes. Factors associated with vaccination intention were analyzed using chi-square tests and logistic regression. Results: Among 2153 caregivers, overall vaccination intention for the 2025 season was 60.10%, markedly higher than the 2024 season’s actual rate (27.45%). Caregiver awareness of this event was 91.92%, primarily via social media (92.02%). In univariate analyses, event-related characteristics were significantly associated with vaccination intention: perceived “completely objective” coverage showed the highest willingness (79.68%, χ2 = 79.92, p < 0.001), whereas the “exaggerated risk” (52.44%) and “unaware” (51.15%) groups showed lower willingness. Exposure frequency also correlated positively: low exposure (0–2 times) had 53.39% willingness, moderate (3–5) 61.11%, and high (≥6) 66.10% (χ2 = 27.75, p < 0.001). However, stronger vaccination intention was independently associated with factors such as no prior vaccination refusal [aOR(95% CI) = 2.74(2.03,3.72)] or hesitancy history [1.47(1.13,1.92)], greater information need (aOR = 6.42–8.83), and disbelief in influenza’s spontaneous resolution [1.39(1.08,1.77)]. Weaker intention was associated with poorer child health status [0.19(0.04,0.74)], no influenza vaccination in 2024 [0.41(0.30,0.55)], no influenza illness in 2024 [0.73(0.56,0.95)], belief in vaccine protection [0.60(0.46,0.79)], and the perception that most parents have their children vaccinated [0.70(0.53,0.93)]. Conclusions: Following a highly publicized celebrity influenza death, vaccination intention was primarily driven by caregivers’ cognitive, psychological, and behavioral experience factors. Caregivers who perceived event coverage as completely objective showed higher vaccination intention, while prior vaccination behavior exhibited inertia. Targeted interventions should enhance information credibility and focus on previously unvaccinated and vaccine-hesitant groups to improve coverage.

  • Open Access

    Spatiotemporal Dynamics and Ecological Correlates of Yersinia pestis F1 Antibody in Domestic Dogs in the Marmota himalayana Plague Focus, 2017–2021

    by Dongyue Lyu, Hanyu Sha, Deming Tang, Daqin Xu, Zhaokai He, Jun Hua, Li Wang, Ran Duan, Shuai Qin, Hua Chun, et al.

    A 5‐year dog cohort established in the Qilian Mountains from 2017 to 2021 was used to elucidate the spatiotemporal dynamics of serum F1 antibody titers and their significance for characterizing plague transmission in animal populations. A total of 1212 serum samples were collected, with an overall F1 seropositivity rate of 83.25% (1009/1212) and a geometric mean titer (GMT) of 1:191.33. Despite the persistently high seropositivity, the GMT exhibited marked seasonality (seasonal strength [SS] = 0.771) and notable interannual variation, with a pronounced peak in 2020 (GMT = 1:356), indicating that GMT provides a more sensitive measure of exposure intensity than seropositivity alone. Individual analysis revealed that puppies’ first natural infection after maternal antibodies wane at 3 months of age causes a sharp increase in titer (from negative to 1:2048), serving as a clear signal of active transmission. Adult dogs showed three characteristic patterns of antibody fluctuation—sustained high exposure, recent exposure, and intermittent exposure—reflecting heterogeneous exposure processes. Spatial analysis identified stable hot spots, indicating significant geographic clustering of dog exposure. Application of the moving epidemic method (MEM) further detected periods of elevated transmission intensity in April (GMT = 1:538) and July (GMT = 1:806) of 2020, which corresponded closely with the isolation of Yersinia pestis from marmots in the same year. These findings show that in endemic foci with high seropositivity rates, the dog serum F1 antibody titers, particularly the complementary changes in GMT levels between adults and puppies, serve as a key indicator for assessing plague transmission intensity, identifying increases in epizootic activity, and evaluating spatial spread. This provides a scientific basis for building a more sensitive and proactive plague surveillance system.